May 14, 2013
, the industry leader in the development of automated proofreading solutions, today announced that it has been selected by Pfizer for worldwide deployment as its proofreading technology solution. This deployment enables Pfizer to drive consistency, reduce costs and subjectivity for artwork and labeling verification throughout the entire packaging workflow process.
With a goal to identify, recommend and implement a global harmonized proofreading technology, a project team was formed within Pfizer to evaluate different technologies that could enhance packaging quality. Global Vision's best-in-class text, artwork, print & barcode technologies were selected by Pfizer to provide complete inspection end-to-end:
- Docu-Proof - text verification and comparison for Regulatory Affairs
- Digital-Page - artwork & proof revision comparator
- ScanTVS - print inspection system
- BarProof - barcode decode & verification
"Protecting your brands integrity is the lifeblood of a company's continued success," explained
, President of Global Vision. "As a global pharmaceutical leader Pfizer's decision to deploy Global Vision's suite of inspection solutions will help ensure that the high quality control standards, synonymous with Pfizer, are maintained."
For more information regarding the Global Vision deployment please listen to the webcast from Packaging Digest: Opportunities in the Global Packaging Market (Minutes 53-57)
About Global VisionGlobal Vision is the world leader in the design and delivery of automated proofreading solutions. Its complete suite of advanced solutions featuring text-based, pixel-based and Braille inspection technologies are designed to eliminate printed artwork, text verification, and text comparison related errors, providing end-to-end security at every stage of the workflow process.
Global Vision solutions are widely interoperable and have received commercial endorsement from the world's leading Pharmaceutical, Consumer Packaged Goods (CPG), and Artwork Management companies.